4//SEC Filing
Ahmadzai David 4
Accession 0001209191-22-019254
CIK 0000708818other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:44 PM ET
Size
13.1 KB
Accession
0001209191-22-019254
Insider Transaction Report
Form 4
Ahmadzai David
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-15$16.37/sh+3,250$53,203→ 47,772 total - Exercise/Conversion
Stock Option (right to buy)
2022-03-15−3,250→ 6,000 totalExercise: $16.37Exp: 2025-06-13→ Common Stock (3,250 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-03-15−3,000→ 3,000 totalExercise: $16.83Exp: 2026-06-01→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-03-15$16.83/sh+3,000$50,490→ 50,772 total - Sale
Common Stock
2022-03-15$19.55/sh−6,250$122,203→ 44,522 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.55 to $19.561. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
- [F2]Original grant of 13,000 options granted on 6/13/2017 vested in four equal, annual installments beginning 6/13/2018.
- [F3]Original grant of 12,000 options granted on 5/30/2018 vests in four equal, annual installments beginning 6/1/2019. Options exercised vested on 6/1/2021. Remaining 3,000 options will vest on 6/1/2022.
Documents
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001813060
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:44 PM ET
- Size
- 13.1 KB